Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

doi:10.3748/wjg.15.2731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4539)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

390

HTML

3699

Figures (1-5)

259

Tables (1-3)

191

Sum=4539

Jun 14, 2009 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Orignal Articles

World J Gastroenterol. Jun 14, 2009; 15(22): 2731-2738
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731

Full Size Figure Download Figure

Figure 2 Effects of celecoxib on cell proliferation. A: Representative Ki-67 staining of gastric mucosa before (A1) and after treatment (A2) with celecoxib; B: Celecoxib led to a significant reduction in proliferation index (PI); C: Celecoxib down-regulated mRNA expression of proliferation cell nuclear antigen (PCNA). 1 and 2: Plecebo; 3 and 4: Celecoxib. Data are mean ± SD. ^bP < 0.01.

Citation: Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 2009; 15(22): 2731-2738
URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2731.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2731